Efficacy and safety of beclomethasone dipropionate versus 5-aminosalicylic acid in the treatment of ulcerative colitis: A systematic review and meta-analysis

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Zhao, Xin ^a   Li, Nan ^a   Ren, YiMing ^a   Ma, Tao ^a   Wang, ChunLi ^a   Wang, Jun ^a   You, ShengYi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; MESALAZINE; ANTIINFLAMMATORY AGENT; BECLOMETASONE; GASTROINTESTINAL AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; BOWEL TENDERNESS; COMPARATIVE EFFECTIVENESS; DEFECATION HABIT; DIARRHEA; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE ACTIVITY INDEX; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENTEROPATHY; FOLLOW UP; HUMAN; INTESTINAL BLEEDING; INTESTINAL MUCOSA QUALITY; INTESTINE MUCOSA; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM HEMORRHAGE; REMISSION; REVIEW; STOOL FREQUENCY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULCERATIVE COLITIS; CHEMICALLY INDUCED; COLITIS, ULCERATIVE; GASTROINTESTINAL HEMORRHAGE;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BECLOMETHASONE; COLITIS, ULCERATIVE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; MESALAMINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84983339565     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0160500     Document Type: Review

References (32)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease:clinical aspects and established and evolving therapies. Lancet. 2007; 369: 1641-1657. PMID: 17499606
2. Bamias G, Cominelli F. Immunopathogenesis of inflammatory boweldisease: current concepts. Curr Opin Gastroenterol. 2007; 23: 365-369. doi: 10.1097/MOG.0b013e3281c55eb2 PMID: 17545770
3. Ananthakrishnan AN. Environmental risk factors for inflammatory boweldiseases: a review. Dig Dis Sci. 2015; 60: 290-298. doi: 10.1007/s10620-014-3350-9 PMID: 25204669
4. Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insuredUS population. Dig Dis Sci. 2013; 58: 519-525. doi: 10.1007/s10620-012-2371-5 PMID: 22926499
5. Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, et al. Health-related quality of life in patients with infl ammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol. 2004; 39: 365-373. doi: 10.1080/00365520310008386 PMID: 15125469
6. Kornbluth A, Sachar DB. Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee Am J Gastroenterol. 2010; 105: 501-23; quiz 524. doi: 10.1038/ajg.2009.727 PMID: 20068560.
7. Feagan B, MacDonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2012; 10: CD000543. doi: 10.1002/14651858.CD000543.pub3 PMID: 23076889
8. Rousseaux C, Lefebvre B, Dubuquoy L, Lefebvre P, Romano O, Auwerx J, et al. Intestinal anti-inflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptorgamma. J Exp Med. 2005; 201: 1205-1215. doi: 10.1084/jem.20041948 PMID: 15824083
9. Hench PS, Slocumb CH, Barnes AR, Smith HL, Polley HF, Kendall EC. The effects of the adrenal cortical hormone 17-hydroxy-11-dehydrocorticosterone (Compound E) on the acute phase of rheumatic fever; preliminary report. Mayo Clin Proc. 1949; 24: 277-297.
10. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J. 1954; 2: 375-378. doi: 10.1136/bmj.2.4884.375 PMID: 13182220
11. Hayashi R, Wada H, Ito K, Adcock IM. Effects of glucocorticoids on gene transcription. Eur J Pharmacol. 2004; 500: 51-62. doi: 10.1016/j.ejphar.2004.07.011 PMID: 15464020
12. Rutgeerts PJ. Review article: the limitations of corticosteroid therapy in Crohn's disease. Aliment Pharmacol Ther. 2001; 15: 1515-1525. doi: 10.1046/j.1365-2036.2001.01060.x PMID: 11563990
13. Bansky G, Bühler H, Stamm B, Häcki WH, Buchmann P, Müller J. Treatment of distal ulcerative colitis with beclomethasone enemas: high therapeutic efficacy without endocrine side effects. A prospective, randomized, double-blind trial. Dis Colon Rectum. 1987; 30: 288-292. doi: 10.1007/BF02556177 PMID: 3030678
14. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011; 365: 1713-1725. doi: 10.1056/NEJMra1102942 PMID: 22047562
15. Kumana CR, Seaton T, Meghji M, Castelli M, Benson R, Sivakumaran T. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. Lancet. 1982; 1: 579-583. PMID: 6121181
16. Rizzello F, Gionchetti P, D'Arienzo A, Manguso F, Di Matteo G, Annese V, et al. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2002; 16: 1109-1116. doi: 10.1046/j.1365-2036.2002.01298.x PMID: 12030952
17. Kumana CR, Seaton T, Meghji M, Castelli M, Benson R, Sivakumaran T. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. Lancet. 1982; 1: 579-583. PMID: 6121181
18. Gionchetti P, Rizzello F, Habal F, Morselli C, Amadini C, Romagnoli R, et al. Standard treatment of ulcerative colitis. Dig Dis. 2003; 21: 157-167. doi: 10.1159/000073247 PMID: 14571113
19. Manguso F, Balzano A. Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis. Aliment Pharmacol Ther. 2007; 26: 21-29. doi: 10.1111/j.1365-2036.2007.03349.x
20. Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.Gastroenterol. 1987; 92: 1894-1898.
21. Campieri M, Adamo S, Valpiani D, D'Arienzo A, D'Albasio G, Pitzalis M, et al. Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study. Aliment Pharmacol Ther. 2003; 17: 1471-1480. doi: 10.1046/j.1365-2036.2003.01609.x PMID: 12823149
22. Gionchetti P, D'Arienzo A, Rizzello F, Manguso F, Maieron R, Lecis PE, et al. Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial. J Clin Gastroenterol. 2005; 39: 291-297. doi: 10.1097/01.mcg.0000155124.74548.61 PMID: 15758622
23. Crispino P, Pica R, Unim H, Rivera M, Cassieri C, Zippi M, et al. Efficacy of mesalazine or beclomethasone dipropionate enema or their combination in patients with distal active ulcerative colitis. Eur Rev Med Pharmacol Sci. 2015; 19: 2830-2837. PMID: 26241537
24. Biancone L, Gionchetti P, Blanco Gdel V, Orlando A, Annese V, Papi C, et al. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study. Dig Liver Dis. 2007; 39: 329-337. doi: 10.1016/j.dld.2007.01.012 PMID: 17347061
25. Mulder CJ, Fockens P, Meijer JW, van der Heide H, Wiltink EH, Tytgat GN. Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis. Eur J Gastroenterol Hepatol. 1996; 8: 549-553. doi: 10.1097/00042737-199606000-00010 PMID: 8823568
26. Franzè A, Galeazzi R, Marcucci F, Biraghi M. Topical treatment of ulcerative colitis. Doubleblind study between beclomethasone dipropionate and mesalazine. Minerva Gastroenterol Dietol. 1999; 45: 287-296. PMID: 16498341
27. Pica N, Unim H, Cassieri C. Oral beclomethasone dipropionate versus 5-aminosalycilic acid enema in active ulcerative colitis patients: lower efficacy but better compliance. Italian. J Med; 64: 189-202.
28. 18th Congresso Nazionale della Societa Scientifica FADOI Giardini Naxos Italy.2013,7:96.
29. Kornbluth A, Sachar DB. Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004; 99: 1371-1385. doi: 10.1111/j.1572-0241.2004.40036.x PMID: 15233681
30. Feagan BG, MacDonald JK. Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: A systematic review and meta-analysis. Inflammatory Bowel Dis. 2012; 18: 1785-1794. doi: 10.1002/ibd.23024
31. Cohen RD, Dalal SR. Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis. Inflamm Bowel Dis. 2015; 21: 1719-36. doi: 10.1097/MIB.0000000000000379 PMID: 26020604
32. Papi C, Aratari A, Moretti A, et al. Oral Beclomethasone Dipropionate as an Alternative to Systemic Steroids in Mild to Moderate Ulcerative Colitis Not Responding to Aminosalicylates. Digestive Diseases & Sciences. 2010; 55: 2002-2007. doi: 10.1007/s10620-009-0962-6